HEPATIC LESION side effect
What is HEPATIC LESION ?Drugs associated with HEPATIC LESION
ARIMIDEX AVELOX AVONEX BARACLUDE DOXORUBICIN FASLODEX FEMARA HUMIRA LAMISIL LEFLUNOMIDE LEVORA PROGRAF RAPAMUNE SECALIP SIROLIMUS TAXOTERE TELITHROMYCIN VALACYCLOVIR VERSEDHEPATIC LESION : Taxotere Side Effects Report #5674824-7
Health Professional from UNITED STATES reported TAXOTERE problem on Mar 14, 2008. Male patient, 72 years of age, weighting 165.8 lb, was diagnosed with pain and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . TAXOTERE dosage: unknown. During the same period patient was treated with LONAFARNIB, DEXAMETHASONE, ACETAMINOPHEN, OXYCODONE, SYNTHROID, OMEPRAZOLE, ADVAIR DISKUS, ALBUTEROL. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Rapamune Side Effects Report #5581989-4
RAPAMUNE problem was reported by a Health Professional from UNITED KINGDOM on Dec 31, 2007. Female patient, weighting 123.5 lb, was diagnosed with renal transplant and was treated with RAPAMUNE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, splenic lesion, . RAPAMUNE dosage: unknown. During the same period patient was treated with PREDNISOLONE, ATORVASTATIN CALCIUM, LANSOPRAZOLE, PERINDOPRIL, ALFACALCIDOL, CALCICHEW, FEMSEVEN, ACETYLSALICYLIC ACID SRT. Patient recovered.
HEPATIC LESION : Levora Side Effects Report #5547264-9
Consumer or non-health professional from SPAIN reported LEVORA problem on Nov 30, 2007. Female patient, 45 years of age, was diagnosed with oral contraception and was treated with LEVORA. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, peliosis hepatis, . LEVORA dosage: unknown. Patient recovered.
HEPATIC LESION : Prograf Side Effects Report #5469703-4
PROGRAF problem was reported by a Physician from GERMANY on Sept 18, 2007. Male patient, weighting 229.3 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, cholelithiasis and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . PROGRAF dosage: 1 MG TABLET/ 11/2-0-1. During the same period patient was treated with PANTOPRAZOLE, METOPROLOL SUCCINATE, URSO FALK, ENALAPRIL MALEATE, CELLCEPT, AMLODIPINE. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Humira Side Effects Report #5390931-0
Physician from UNITED STATES reported HUMIRA problem on July 12, 2007. Male patient, 76 years of age, was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, neoplasm malignant, . HUMIRA dosage: unknown. Patient died on 01/01/2003.
HEPATIC LESION : Baraclude Side Effects Report #5399371-1
BARACLUDE problem was reported by a Consumer or non-health professional from CHINA on July 25, 2007. Male patient was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . BARACLUDE dosage: unknown. Patient recovered.
HEPATIC LESION : Humira Side Effects Report #5390931-0
Physician from UNITED STATES reported HUMIRA problem on July 12, 2007. Male patient, 76 years of age, was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, neoplasm malignant, . HUMIRA dosage: unknown. Patient died on 01/01/2003.
HEPATIC LESION : Baraclude Side Effects Report #5399371-1
BARACLUDE problem was reported by a Consumer or non-health professional from CHINA on July 25, 2007. Male patient was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, . BARACLUDE dosage: unknown. Patient recovered.
HEPATIC LESION : Leflunomide Side Effects Report #5652175-4
Consumer or non-health professional from FRANCE reported LEFLUNOMIDE problem on Feb 18, 2008. Female patient, 34 years of age, was diagnosed with juvenile arthritis, therapeutic procedure and was treated with LEFLUNOMIDE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, hepatic lesion, hepatic necrosis, hepatitis fulminant, hepatomegaly, hepatotoxicity, vitamin k deficiency, . LEFLUNOMIDE dosage: 20 MG/DAY. During the same period patient was treated with CHOLESTYRAMINE, ACETAMINOPHEN W. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Humira Side Effects Report #5654075-2
HUMIRA problem was reported by a Health Professional from UNITED KINGDOM on Feb 26, 2008. Female patient, weighting 114.6 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: disseminated tuberculosis, hepatic lesion, infection, lung neoplasm, malaise, spleen disorder, . HUMIRA dosage: unknown. During the same period patient was treated with SULFASALAZINE, METHOTREXATE, PARAMOL, ETODOLAC, FOLIC ACID. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Avonex Side Effects Report #5671012-5
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Mar 03, 2008. Female patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, hepatic lesion, kidney small, renal artery stenosis, thrombosis, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Secalip Side Effects Report #5619137-4
SECALIP problem was reported by a Physician from GERMANY on Jan 30, 2008. Male patient, 40 years of age, was diagnosed with hypercholesterolaemia, immunisation and was treated with SECALIP. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, hepatic lesion, renal failure chronic, rhabdomyolysis, . SECALIP dosage: unknown. During the same period patient was treated with HEPATITIS B SURFACE ANTIGEN, INFLUENZA VIRUS VACCINE POLYVALENT, INFLUENZA VIRUS VACCINE POLYVALENT, INFLUENZA VIRUS VACCINE POLYVALENT. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Avelox Side Effects Report #5636297-X
Physician from GERMANY reported AVELOX problem on Feb 17, 2008. Female patient was treated with AVELOX. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatic lesion, pyrexia, sepsis, white blood cell count increased, . AVELOX dosage: unknown. Patient died.
HEPATIC LESION : Lamisil Side Effects Report #5419271-8
LAMISIL problem was reported by a Physician from GERMANY on Aug 17, 2007. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, intestinal operation, neuroendocrine carcinoma, . LAMISIL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
HEPATIC LESION : Lamisil Side Effects Report #5419275-5
Physician from GERMANY reported LAMISIL problem on Aug 17, 2007. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with onychomycosis and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: hepatic lesion, intestinal operation, neuroendocrine carcinoma, . LAMISIL dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
HEPATIC LESION : Femara Side Effects Report #5379655-3
FEMARA problem was reported by a Physician from ITALY on June 25, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.
HEPATIC LESION : Femara Side Effects Report #5381726-2
Consumer or non-health professional from ITALY reported FEMARA problem on June 29, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.
HEPATIC LESION : Doxorubicin Side Effects Report #5392263-3
DOXORUBICIN problem was reported by a Consumer or non-health professional from CANADA on July 11, 2007. Female patient was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, hepatic lesion, peritoneal lesion, . DOXORUBICIN dosage: unknown. Patient recovered.
HEPATIC LESION : Femara Side Effects Report #5379655-3
Physician from ITALY reported FEMARA problem on June 25, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.
HEPATIC LESION : Femara Side Effects Report #5381726-2
FEMARA problem was reported by a Consumer or non-health professional from ITALY on June 29, 2007. Female patient, 73 years of age, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: gastric cancer, hepatic lesion, hepatic mass, . FEMARA dosage: 2.5 MG/D. Patient recovered.
HEPATIC LESION : Doxorubicin Side Effects Report #5392263-3
Consumer or non-health professional from CANADA reported DOXORUBICIN problem on July 11, 2007. Female patient was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: erythema, hepatic lesion, peritoneal lesion, . DOXORUBICIN dosage: unknown. Patient recovered.
HEPATIC LESION : Valacyclovir Side Effects Report #5653409-2
VALACYCLOVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Female patient, 53 years of age, was treated with VALACYCLOVIR. After drug was administered, patient experienced the following problems/side effects: ear infection, headache, hepatic lesion, lymphadenopathy, panic attack, pruritus, sarcoidosis, . VALACYCLOVIR dosage: 500MG TWICE PER DAY. Patient recovered.
HEPATIC LESION : Arimidex Side Effects Report #5586836-2
Consumer or non-health professional from UNITED STATES reported ARIMIDEX problem on Jan 04, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic enzyme increased, hepatic lesion, metastases to spine, nausea, tumour marker increased, . ARIMIDEX dosage: unknown. During the same period patient was treated with ARIDIA. Patient recovered.
HEPATIC LESION : Faslodex Side Effects Report #5586837-4
FASLODEX problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic enzyme increased, hepatic lesion, metastases to spine, nausea, tumour marker increased, . FASLODEX dosage: unknown. During the same period patient was treated with ARIDIA. Patient recovered.
HEPATIC LESION : Versed Side Effects Report #5553887-3
Pharmacist from UNITED STATES reported VERSED problem on Dec 12, 2007. Female patient, 67 years of age, was treated with VERSED. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, erythema, hepatic lesion, hypertension, hypotension, labile blood pressure, liver function test abnormal, . VERSED dosage: unknown. During the same period patient was treated with FENTANYL. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Telithromycin Side Effects Report #5573038-9
TELITHROMYCIN problem was reported by a Consumer or non-health professional from GREECE on Dec 19, 2007. Female patient, 66 years of age, was diagnosed with hypertension and was treated with TELITHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chromaturia, fatigue, hepatic lesion, jaundice, . TELITHROMYCIN dosage: unknown. During the same period patient was treated with IRBESARTAN. Patient was hospitalized. Patient recovered.
HEPATIC LESION : Sirolimus Side Effects Report #5477901-9
Health Professional from AUSTRALIA reported SIROLIMUS problem on Oct 02, 2007. Female patient, 67 years of age, was diagnosed with renal transplant and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: axillary mass, blood creatinine increased, hepatic lesion, liver function test abnormal, metastases to bone marrow, neuroendocrine carcinoma of the skin, oedema peripheral, . SIROLIMUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, CICLOSPORIN. Patient died.